Anti-Genetic Engineering Activism: Why the Bastards Never Quit
Henry Miller and Robert Macgregor (GEN)
Has The Pendulum Swung Too Far in Favor of Rare Diseases?
Stewart Lyman (Xconomy)
Twitter, social media are fertile ground for stock hoaxes
Please be careful out there!
Immunokinase Drug Candidates: $12B in Value Creation and Counting
Bruce Booth (LifeSciVC Blog)
JAKs, PI3Ks, BTKs, SYKs, oh my!